Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis

NCT02755857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenia

Interventions

DRUG: Lozanoc

Sponsor

Mayne Pharma International Pty Ltd